Cara Therapeutics (CARA) Reports Q2 Loss of $0.29/Share
Cara Therapeutics (NASDAQ: CARA) reported Q2 EPS of ($0.29), versus ($0.48) reported last year.
For earnings history and earnings-related data on Cara Therapeutics (CARA) click here.
Cara Therapeutics (NASDAQ: CARA) reported Q2 EPS of ($0.29), versus ($0.48) reported last year.
For earnings history and earnings-related data on Cara Therapeutics (CARA) click here.